Resalis Therapeutics
Treatments for metabolic diseases
Total raised
€20M
€20,000,000
Funding rounds
2
Investors
5
distinct backers
Active since
2023-02
latest 2024-01
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-04 | Series A | €10M | Angel Investors,Claris Ventures,Sunstone Life Science Ventures | View deal → |
| 2023-02-22 | Seed | €10M | Claris Ventures,Italian Angels for Growth,Pietro Puglisi | View deal → |
Investors
5Related news
- Resalis Therapeutics Raises €10M in Seed Financingfinsmes.com · 2023-02
- eu-startups.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech